Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - Preliminary report

European Journal of Cancer

Volumn 41, Issue 1, 2005, Pages 143-150

  Majdak, Ewa J ^a,b   De Bock, Geertruida H ^b   Brozek, Izabela ^a   Perkowska, Magdalena ^a   Ochman, Karolina ^a   Debniak, Jaroslaw ^a   Milczek, Tomasz ^a   Cornelisse, Cees J ^b   Jassem, J ^a   Emerich, Janusz ^a   Limon, Janusz ^a   Devilee, Peter ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1, BRCA2; Clinical correlations; Hereditary ovarian carcinoma; Unclassified variants

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CARCINOGENICITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GEL ELECTROPHORESIS; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HYPERTHYROIDISM; INFERTILITY; MAJOR CLINICAL STUDY; MEDICAL RECORD; MUTATIONAL ANALYSIS; ONCOGENE; OVARY CARCINOMA; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; HYPERTHYROIDISM; INFERTILITY, FEMALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 19944422091     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.10.011     Document Type: Article

References (36)

1. ACOG Committee Opinion. Genetic risk and screening techniques for epithelial ovarian cancer. Int J Gynec Obstet 1993, 41, 321-323
2. C.F. Xu, J.A. Chambers, and H. Nicolai Mutations and alternative splicing of the BRCA1 gene in the UK breast/ovarian cancer families Gene Chromosom Cancer 18 1997 102 110
3. S. Mazoyer, N. Puget, and L. Perrin-Vidonz A BRCA1 nonsense mutation causes exon skipping Am J Hum Genet 62 1998 713 715
4. H. Ozcelik, R. Nedelcu, and V.W.Y. Chan Mutations in the coding region of the BRCA1 gene leads to aberrant splicing of the transcript Hum Mutat 14 1999 540 541
5. H.X. Liu, L. Cartegni, and M.Q. Zhang A mechanism of exon skipping caused by nonsense or missense mutations in BRCA1 and other genes Nat Genet 27 2001 55 58
6. A. Vega, B. Campos, and B. Bressac de Pailleets The R71G BRCA1 is a founder Spanish mutation and leads to abberant splicing of the trancript Hum Mutat 17 2001 520 521
7. J.D. Feckenthal, L. Cartegni, and A.R. Krainer BRCA2 T2722R is a deleterious allele that causes exon skipping Am J Hum Genet 71 2002 625 631
8. R.S. Williams, and J.N. Glover Structural consequences of a cancer-causing BRCA1-BRCT missense mutation J Biol Chem 278 2003 2630 2635
9. M.A. Fleming, J.D. Potter, and C.J. Ramirez Understanding missense mutations in the BRCA1 gene: an evolutionary approach Proc Natl Acad Sci USA 100 2003 1151 1156
10. D.F. Easton, D. Ford, and D.T. Bishop Breast and ovarian cancer incidence in BRCA1 mutation carriers Am J Hum Genet 56 1995 265 271
11. E.B. Claus, J.M. Schildkraut, and W.D. Thomposn The genetic attributable risk of breast and ovarian cancer Cancer 77 1996 2318 2324
12. H. Anton Culver, P.F. Cohen, and M.E. Gldeea Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer Eur J Cancer 36 2000 1200 1208
13. A. Dorum, E. Hovig, and C. Trope Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA Eur J Cancer 35 1999 779 781
14. J.P. Geisler, M.A. Hatterman-Zogg, and J.A. Rather Frequency of BRCA1 dysfunction in ovarian cancer J Natl Cancer Inst 94 2002 61 67
15. W.H. Gotlieb, E. Friedman, and R.B. Bar-Sade Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumours J Natl Cancer Inst 90 1998 995 1000
16. S.A. Janezic, A. Ziogas, and L.M. Krumroy Germline BRCA1 alterations in a population-based series of ovarian cancer cases Hum Mol Genet 8 1999 889 897
17. K.H. Lu, D.W. Cramer, and M.G. Muto A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer Obstet Gynecol 93 1999 34 37
18. B. Modan, E. Gak, and R.B. Sadebruchim High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel JAMA 276 1996 1823 1825
19. R. Moslehi, W. Chu, and B. Karlan BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 66 2000 1259 1272
20. P. Mullen, W.R. Miller, and J. Mackay BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland Br J Cancer 75 1997 1377 1380
21. L. Sarantaus, P. Vahteristo, and E. Bloom BRCA1 and BRCA2 mutations among 233 unselected finnish ovarian carcinoma patients Eur J Hum Genet 9 2001 424 430
22. J.F. Stratton, S.A. Gayther, and P. Russell Contribution of BRCA1 mutations to ovarian cancer N Engl J Med 336 1997 1125 1130
23. J.H. Shephard Revised FIGO staging for gynaecological cancer Br J Obst Gynaecol 96 8 1989 889 892
24. J. Boyd, Y. Sonoda, and M.G. Federici Clinicopathologic features of BRCA-linked and sporadic ovarian tumours JAMA 283 2000 2260 2266
25. B. Górski, T. Byrski, and J. Lubinski Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer Am J Hum Genet 66 2000 1963 1968
26. M. Perkowska, I. Brożek, and B. Wysocka BRCA1 and BRCA2 mutation analysis in breast-ovarian families from Northeastern Poland Hum Mutat 21 2003 553 554
27. J. Boyd, and S. Rubin Hereditary ovarian cancer: molecular genetics and clinical implications - review Gynecol Oncol 64 1997 196 206
28. O.T. Johannsson, J. Tanstam, and A. Borg Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden J Clin Oncol 16 1998 397 404
29. K.H. Lu, and R.R. Broaddus Gynecologic tumours in HNPCC: we know they are common - now what? Gynecol Oncol 82 2001 337 340
30. H.T. Lynch, P. Watson, and C. Bewtra Hereditary ovarian cancer. Heterogeneity at age of diagnosis Cancer 67 1991 1460 1466
31. J.N. Marcus, P. Watson, and D.L. Page Hereditary breast cancer pathobiology, prognosis and BRCA1 and BRCA2 gene linkage Cancer 77 1996 687 709
32. S.A. Narod, P. Sun, and P. Ghadirian Tubal ligation and risk of ovarian cancer in carriers of BRCA1 and BRCA2 mutations - a case control study Lancet 12 357 2001 1467 1470
33. M.B. Martinez, M. Ruan, and L.A. Fitzpatrick Altered response to thyroid hormones by breast and ovarian cancer cells Anticancer Res 20 2000 4141 4146
34. L. Skjoldebrand Sparre, M. Kollind, and K. Carlstrom Ovarian ultrasound and ovarian and adrenal hormones before and after treatment for hyperthyroidism Gynecol Obstet Invest 54 2002 50 55
35. R.B. Ness, and C. Cottreau Possible role of ovarian epithelial inflammation in ovarian cancer J Natl Cancer Inst 91 17 1999 1459 1467
36. R.B. Ness, C. Cottreau, and J. Kapplar Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer Epidemiology 11 2 2000 97 98